News | Heart Valve Technology | June 19, 2020

SMT Enters Structural Heart Market With Acquisition of Vascular Concepts

TAVR is quickly becoming the preferred option for majority of the heart valve patients in India

SMT Enters Structural Heart Market With Acquisition of Vascular Concepts. The company's Hydra TAVR (TAVI) valve gained European CE mark clearance in June 2020.

June 19, 2020 — SMT (Sahajanand Medical Technologies Pvt. Ltd) said it acquired of the structural heart medical device firm Vascular Concepts. The acquisition was completed May 27. 

The company recently gained European CE mark for its Hydra transcatheter aortic valve implantation (TAVI) system in early June 2020.

Vascular Concept will retain its distinct brand and independence and Swaminathan Jayaraman, CEO of Vascular Concept, will continue to manage the operation of the company.

The company has operations in India and Thailand and has more than 200 employees, with two manufacturing sites and two research and development centers. 

It is one of the oldest Indian medical device companies, established in 1988. It has a diversified product portfolio which includes coronary stents, cardiac closure devices, peripheral stents, unique balloon catheters like percutaneous transvenous mitral commissurotomy (PTMC) balloons and transcatheter aortic valve replacement (TAVR) devices.

Vascular Concept developed and launched the Hydra transcatheter aortic valve system, which received Indian regulatory approval in 2020. It is used for the treatment of high-risk patients suffering from severe and symptomatic aortic valve stenosis. The Hydra TAVR system is a self-expanding supra-annular transcatheter aortic valve, which presents unique design features and similar event rates compared to contemporary devices in separate clinical studies conducted in India and Europe. The TAVI market is growing at about 20% worldwide, Europe and the U.S. being the main markets to date.

“The structural heart segment is a fast-growing segment in cardiovascular industry. We strongly believe that SMT will play a major role within this segment and provide solutions to benefit patients and its wide customer base," explained Dhirajlal Kotadia, chairman of SMT. "Acquisition of Vascular Concepts Group reflects our commitment to become a leader in TAVI and structural heart technologies.”

“We are excited to join hands with SMT, who have a strong leadership in interventional cardiology and has demonstrated aggressive growth in this business," said Jayaraman. "This association will create tremendous market opportunities for both companies to grow in structural heart disease. Vascular Concepts is committed to driving further innovation in the field of structural heart, which can be commercialized together with SMT.”

With an addition of aortic valve to its product categories, SMT advances in its mission to provide best-in-class cardiac care to the healthcare community and patients. 

 

Related SMT Cardiology Device Content:

SMT Hydra TAVR System Receives European CE Mark Approval 

Innovations in Cardiovascular Disease Treatment and the Rising Demand for Stents 

Supraflex Drug-Eluting Stent Superior to Xience in Two-Year Target Vessel Failure

Coronary Stent Market Characterized by New Drug-eluting Stents
 

Related Content

Image from the announcement of the Neal award winner of best technical content for DAIC's coverage of COVID-10 related to cardiology at the Neal virtual award ceremony June 9.

Image from the announcement of the Neal award winner of best technical content for DAIC's coverage of COVID-10 related to cardiology at the Neal virtual award ceremony June 9.

Feature | Cardiovascular Business | June 10, 2021
Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.

Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.

News | Cardiovascular Business | May 05, 2021
May 5, 2021 — A late-breaking study presented at the...
Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman. Hopes to build the Cordis Accelerator for innovative cardiovascular device development.
News | Cardiovascular Business | March 12, 2021
March 12, 2021 — Cardinal Health today announced that it is selling its...
An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies. 

An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies. 

News | Cardiovascular Business | February 03, 2021
February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat...
COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States. #DAIC

COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States.

Feature | Cardiovascular Business | December 01, 2020 | Dave Fornell, Editor
December 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC
Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.

Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.

News | Cardiovascular Business | September 14, 2020
September 14, 2020 — New global research released by Abbott takes a deep dive into the barriers of cardiovascular pat
Philips angiography system in a cath lab at Henry Ford Hospital.
Feature | Cardiovascular Business | July 13, 2020 | Deb Thompson and Christian Comeau
For a cardiovascular service line leader, addressing challenges in an evolving healthcare climate is a constant.
Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business | July 08, 2020
July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agree